Company intelligence / Profile preview

Yessamin Health

Ownership: Private
Development stage: Other

Overview

Yessamin Health was a contract manufacturer specializing in the production and packaging of tablets, hard two-piece gelatin capsules, vegetarian capsules, and softgels for the nutraceuticals industry. The company operated BRC-, NSF-, and GMP-certified facilities before being acquired by TSI Group in 2011–2012 to strengthen TSI’s global manufacturing capabilities. No clinical results are available as it was not a drug development company. Post-acquisition, it integrated into the broader TSI network, functioning primarily as a contract manufacturing organization (CMO) for nutraceutical and dietary supplement products.

Modalities: TabletsHard two-piece gelatin capsulesVegetarian capsulesSoftgels
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Yessamin Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yessamin Health.

Explore the full profile